FDA
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) Announces U.S. FDA Accelerated Approval of Zepzelca for Treatment of Metastatic Small Cell Lung Cancer
-
-
-
-
-
-
-
Positive results of lurbinectedin Phase II trial (PharmaMar) for the treatment of relapsed small cell lung cancer are presented at ASCO
-
-
-
-
-
-
-
PharmaMar Will Commercialize PM1183 With the Trade Name of Zepsyreâ„¢
-
-
-
-
-
251,772 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All